SMO and site coordinator support for clinical studies in Türkiye
Site identification, coordinator resourcing, start-up documentation and site-level quality oversight — designed so sponsors get predictable site performance without compromising monitoring independence.
Illustrative study workflow
Clinical research
What site management support covers
A site management organization works at the level where studies usually succeed or stall: the clinic. Our scope is defined per study and documented alongside the sponsor's monitoring plan, so responsibilities never overlap ambiguously.
Site identification and feasibility
Structured feasibility with defined data inputs, investigator questionnaires and challenge sessions that test optimistic recruitment estimates before a site is selected.
Coordinator resourcing models
Study coordinator support arranged per selected site — site-employed, dedicated or shared across nearby centres — with responsibilities documented in the site delegation plan.
Start-up documentation support
Site-level document collection, delegation logs, training records, source documentation planning and readiness checks ahead of site initiation.
Visit and logistics coordination
Subject visit scheduling support, sample logistics coordination with the central laboratory, product accountability documentation and query turnaround tracking.
Site-level quality oversight
Deviation capture and escalation, CAPA follow-through at site level, and preparation support for sponsor monitoring visits and audits under ICH-GCP.
Regional coordination planning
A regional coordination structure that can be scaled across provinces per study, activated after feasibility and contracting rather than maintained as standing coverage.
Investigator Engagement
Structured conversations, documented follow-through
Early investigator engagement is handled as a consent-aware qualification process. The goal is to understand fit, constraints and the next evidence needed — not to promise a study, budget or recruitment outcome.
- 1
Profile the institution and specialty
Capture only the information needed to understand the centre, relevant experience and decision pathway, with a documented lawful basis for contact.
- 2
Assess capacity and patient potential
Review the study team, infrastructure, routinely followed populations and operational constraints without turning early estimates into promises.
- 3
Match the collaboration model
Connect the identified need to an appropriate option such as feasibility preparation, site start-up support, coordinator resourcing or investigator-initiated research support.
- 4
Record the next action
Close each discussion with a named internal owner, a defined follow-up date, required information and a clear opportunity status.
How the nationwide coordination model works
CliniGA maintains a regional coordination framework covering Türkiye's provinces as a planning structure. For each study, the provinces in scope are determined by feasibility: indication prevalence, site capability, investigator interest and logistics. Coordination resources are then contracted for those provinces.
We describe this deliberately as scalable capability rather than existing coverage. Sponsors should plan against contracted, study-specific commitments — and we will state clearly which sites and provinces are confirmed at each stage.
- 1
Scope
Agree indication, target sites, subject numbers and the split of responsibilities with the sponsor and CRO.
- 2
Feasibility
Identify candidate provinces and sites, validate interest and capability, and stress-test recruitment assumptions.
- 3
Activation
Contract coordination resources for the selected sites, complete start-up documentation and train the site team.
- 4
Conduct
Coordinate visits, data entry timeliness and query resolution; capture deviations and escalate on defined triggers.
- 5
Close-out
Complete site documentation, product accountability and archiving hand-over in the agreed format.
Frequently asked questions
- Does CliniGA already staff coordinators in all 81 provinces of Türkiye?
- No. CliniGA operates a scalable nationwide coordination model: a regional structure that can be extended province by province for a specific study. Coverage for any given province is planned service capability, activated only after feasibility assessment and contracting — not an existing staffed network.
- How is SMO support kept separate from monitoring?
- Site-level support and sponsor-side monitoring are defined as separate roles in the contract and the quality plan, so that monitoring independence and sponsor oversight remain intact even when one provider delivers both.
- Can SMO support be contracted without full CRO services?
- Yes. Site coordination can be scoped as a standalone service alongside a sponsor's existing CRO, provided responsibilities, escalation paths and system access are agreed in writing.
- How quickly can a site be supported after selection?
- It depends on institutional contracting, ethics and authority timelines, and coordinator availability. We provide ranges with named assumptions rather than fixed dates.
Related reading: clinical trial regulatory support in Türkiye, choosing CRO services in Türkiye and the site network and feasibility pathway, and our clinical research services.
Planning a study with sites in Türkiye?
Share the protocol scope and target provinces. We respond with a feasibility approach and a site coordination plan built on stated assumptions.
